These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 17581787)
21. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin. Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791 [TBL] [Abstract][Full Text] [Related]
22. Clinical experience with recombinant tissue plasminogen activator in the management of intracardiac and arterial thrombosis in children. Olgun H; Buyukavci M; Ceviz N; Sahin IO; Yildirim ZK; Colak A; Tekgunduz KS; Caner I Blood Coagul Fibrinolysis; 2014 Oct; 25(7):726-30. PubMed ID: 24806322 [TBL] [Abstract][Full Text] [Related]
23. Advantages and disadvantages of using intravenous tissue Plasminogen activator as salvage therapy for inoperable HeartWare thrombosis. Basken R; Bazzell CM; Smith R; Janardhanan R; Khalpey Z J Card Surg; 2017 Jul; 32(7):443-446. PubMed ID: 28631345 [TBL] [Abstract][Full Text] [Related]
25. [Thrombosis valvular prosthesis of Starr treated successfully by tenecteplase during pregnancy]. Slaoui M; Cherradi R; Ounzar M; Massou S; Srairi JE Ann Fr Anesth Reanim; 2010 Jun; 29(6):500-1. PubMed ID: 20573480 [No Abstract] [Full Text] [Related]
26. Successful thrombolysis in patients with subacute and late stent thrombosis. Sciahbasi A; Patrizi R; Madonna M; Summaria F; Scioli R; Carlino G; Lioy E Can J Cardiol; 2009 Jun; 25(6):e213-4. PubMed ID: 19536398 [TBL] [Abstract][Full Text] [Related]
33. Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator. DeMeo SD; Sherwood A; Hornik CD; Goldberg RN; Cotten CM; Bidegain M J Perinatol; 2014 Jul; 34(7):569-71. PubMed ID: 24968902 [TBL] [Abstract][Full Text] [Related]
34. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management. Jennings DL; Weeks PA Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333 [TBL] [Abstract][Full Text] [Related]
35. Life threatening cavopulmonary thrombus: resolution within 24 h with tissue plasminogen activator. Malagon I; Evens FC; Freund MW Paediatr Anaesth; 2008 Apr; 18(4):343-4. PubMed ID: 18315651 [No Abstract] [Full Text] [Related]
36. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions. Mathur M; Desai N; Sharma J; Rao SP; Goldman GM Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665 [TBL] [Abstract][Full Text] [Related]
37. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis. Al-Quthami AH; Jumean M; Kociol R; Pham DT; Kiernan M; DeNofrio D; Kapur NK Circ Heart Fail; 2012 Jul; 5(4):e68-70. PubMed ID: 22811551 [No Abstract] [Full Text] [Related]
38. Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy. Thenappan T; Anderson AS; Jeevanadham V; Rich JD; Shah AP Circ Heart Fail; 2013 May; 6(3):e27-9. PubMed ID: 23694774 [No Abstract] [Full Text] [Related]
39. [Successful lysis of a mobile left ventricular thrombus by slow infusion of low-dose tissue plasminogen activator]. Güneş Y; Ceylan Y; Tuncer M Turk Kardiyol Dern Ars; 2010 Oct; 38(7):489-91. PubMed ID: 21206203 [TBL] [Abstract][Full Text] [Related]
40. Resolution of hyphaema following intracameral injection of tenecteplase in a Stock Horse. Rendle DI; Hughes KJ Aust Vet J; 2013; 91(1-2):31-4. PubMed ID: 23356369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]